ABSTRACT
High-flow nasal cannula oxygen therapy (HFNC) in palliative care is mentioned in several guidelines, however, the indication for this procedure has not been established yet. At our department, HFNC has increasingly been adopted for end-stage cancer patients when their dyspnea needs to be alleviated. This is a case report on three patients treated with this procedure at our department. Although they had severe dyspnea with respiratory failure, their daily activities, such as enjoying meals and conversation with their families, were improved with HFNC. It can be a treatment of choice to maintain and improve patients’ quality of life (QOL) in palliative setting, where benefits and risks should be considered for each patient.
ABSTRACT
La pandemia por el virus SARS-COV2 que causó la enfermedad COVID-19 ha traído grandes desafíos al sistema de salud tanto a nivel nacional como mundial. En Chile, gracias al esfuerzo de organismos gubernamentales e instituciones privadas, los centros de salud se han equipado con distintos dispositivos de terapia ventilatoria (ventilación mecánica invasiva y no invasiva, y terapia de alto flujo de oxígeno mediante cánula nasal (TAF) con la finalidad de abarcar mayor atención de pacientes tras un periodo de crisis sanitaria que colapsó las redes de atención secundaria y terciaria de salud. En concordancia a esto, es interesante evaluar qué utilidad puede darse a estos equipos posterior a la pandemia, considerando que en varios centros de salud se duplicó o triplicó la disponibilidad de recursos técnicos. En este contexto, la TAF entrega efectos fisiológicos favorables y útiles en escenarios clínicos que implican aumento de las demandas ventilatorias, no sólo en condiciones de insuficiencia respiratoria hipoxémica aguda, sino en condiciones en donde el ejercicio aeróbico es un pilar fundamental, como es el caso de los diferentes programas de rehabilitación (cardiovascular, respiratorio, metabólico, etc.) incluidos como Garantías Explícitas de Salud (GES). Así, la incorporación de TAF en la rehabilitación pulmonar sería una opción adecuada en pacientes con disfunciones respiratorias crónicas, ampliando la cobertura sanitaria que estos programas tienen hoy en día.
The SARS-COV2 pandemic that caused the COVID-19 disease has brought significant challenges to the health system nationally and globally. In Chile, thanks to the efforts of government agencies and private institutions, health centres have been equipped with di-fferent ventilatory therapy devices (invasive and non-invasive mechanical ventilation, and high-flow oxygen therapy by nasal cannula (HFOT)), in order to cover more patient care after a period of a health crisis that collapsed secondary and tertiary health care networks. Accordingly, it is interesting to evaluate concerning what use can be given to these teams after the pandemic, even more considering that the availability of technical resources doubled or tripled in several health centres. In this context, HFOT provides favourable and useful physiological effects in clinical scenarios that involve increased ventilatory demands, not only in conditions of acute hypoxemic respiratory failure but also in conditions where aerobic exercise is a fundamental pillar, as is the case of the different rehabilitation programs (cardiovascular, respiratory, metabolic, etc.) included as Health Guarantees (Garantías Explicitas en Salud, GES). Thus, incorporating HFOT in pulmonary rehabilitation would be an appropriate option in patients with chronic respiratory dysfunctions, expanding the health coverage that these programs have today.
ABSTRACT
Objective T o analyze the influence of high flow nasal cannula (HFNC) on trespiratory mechanical parameters of the patient with acute respiratory distress syndrome (ARDS) based on ventilation experiment, and investigate the therapeutic and side effects of the HFNC. Methods The HFNC ventilation system model based on MATLAB and the physical experiment platform based on active simulated lung ASL5000 were developed to simulate the respiratory movement of ARDS patients with different lung compliance, and a series of the HFNC ventilation experiments were carried out. Both experimental results in MATLAB and physical platform were compared and analyzed. Results The results from the Matlab model-based simulation experiment and physical platform based-physical experiment uniformly showed that increasing the output flow of HFNC would decrease the relevant respiratory mechanical parameters of respiratory flow and tidal volume, but increase the intrapulmonary pressure and the functional residual capacity (FRC). Under the condition of small flow, the output flow from HFNC might be smaller than the inspiratory flow required by the patient, and an inspiratory compensation flow was necessary to make up for the inspiratory flow. Conclusions The necessary reliable compensation flow in inspiration will promote the security of HFNC. Understanding the changes in respiratory mechanical parameters of ARDS patient will be beneficial to pre-evaluate the HFNC, improve the ventilation effect and reduce the ventilation risks.
ABSTRACT
Background: High-flow nasal cannula (HFNC) oxygen therapy is carried out using an air/oxygen blender, active humidifier, single heated tube, and nasal cannula. It is an oxygen delivery system which uses air blender to deliver accurate oxygen concentration to the patient from 21% to 100% at desired temperature. It can be administered via wide bore nasal cannula or to the tracheostomy tube via connector. It can give upto 60L/min flow hence can generate positive end expiratory pressure between 2 to 7 cmH20. By providing humidified oxygen along with the high flow rates it satisfies air hunger and reduces work of breathing for the patient.Methods: This is a retrospective observational study. Patients with persistent hypoxia in spite of conventional oxygen therapy were treated with HFNC. Patients with possible need for immediate invasive ventilator support were excluded. Clinical respiratory parameters and oxygenation were compared under conventional and HFNC oxygen therapy.Results: Thirty patients, aged more than 18 years admitted in intensive respiratory care unit with acute hypoxemic respiratory failure from June 2017 to January 2018 were included in the study. Study period was of 6 months. Etiology of acute respiratory failure (ARF) was mainly pneumonia (n = 17), interstitial lung disease (n = 5), bronchial asthma (n=3) and others (n = 5). There was statistically significant reduction in respiratory rate (29.40 before Vs 23.50 after; P- <0.0001) and significant improvement in comfort level of the patient after HFNC therapy. Median duration of HFNC was 48 hrs (24-360) hours. Five patients were intubated later on and 4 died in the intensive care unit.Conclusions: Use of HFNC in patients with persistent ARF was associated with significant and sustained improvement of clinical parameters (respiratory rate). It can be used comfortably for prolonged periods.
ABSTRACT
Objective To compare the clinical effects of high flow nasal cannula (HFNC) and non-rebreathing oxygen face mask (NRB) in post-extubation patients.Methods 88 critically ill patients with machinery ventilations were divided into HFNC group and NRB group randomly.Blood gas analysis and hemodynamic parameters were assessed 1 hour prior to extubation and 6 hours after extubation.The primary clinical outcomes measured were ventilation-free days,re-intubation patient numbers,length of stay in ICU (Intensive Care Unite),total duration of hospitalization and mortality.The scant of breath degree and comfortableness of patient were recorded according to the Visual analogue scale.The measurement data were described by mean ± standard deviation ((x) ± s) and analyzed with t test,enumeration data were described by number of cases and composition ratio and analyzed with X2test,P ＜ 0.05 was considered to have statistical difference.Results There was no significant difference in clinical features between the two groups,The oxygenation index of HFNC group is significantly higher than that of NRB group after extubation [(251.4 ±43.9) vs.(201.7 ±60.7),P =0.037)].There were more ventilator-free days in the HFNC group than NRB group [(4.2 ± 2.1) vs.(3.4 ± 2.8),P =0.037)] and fewer patients required reintubation (P =0.028).The rate of ventilator associated pneumonia is also lower than NRB group (P =0.024).The patients' scant of breath feeling were obviously allevated comparing with the NRB group [(2.9 ± 1.1) vs.(3.7 ± 1.8),P =0.042)].The oxygenation index of NRB group significantly decreased after extubation [(242.9 ±68.4vs.201.7 ±60.7 P =0.048)].The two groups demonstrated similar hemodynamic patterns before and after extubation.And there were no statistically significant clinical differences in PaCO2,length of ICU stay,total duration of hospitalization or mortality.Conclusions Compared with NRB,HFNC is a more safe and effective clinical tool in the prevention and treatment of critical adult patients with extubation failure.